Robert Carlson is a principal at Biodesic, a biological engineering, consulting, and design firm in Seattle. He earned a doctorate in physics from Princeton University and is interested in the future role of biology as a human technology. He is the author of Biology Is Technology: The Promise, Peril, and Inevitability of Engineering Life, to be published in late 2009.
The majority of biotech products that have reached the market are the result of just a handful of genetic modifications and insertions. The commercial significance of the biotech sector will grow as its ability to engineer new biological systems expands.
Send an e-mail to let us know how we can make our site better.
The Stanford Social Innovation Review is written for and by social change leaders in the nonprofit, business, and government sectors. Sample articles of particular interest to readers of What Matters are available below.
by Ben Hecht. Living Cities is working with five US municipalities to develop an ecosystem for solving urban problems.
by Clayton M. Christensen, Shuman Talukdar, Richard Alton, and Michael B. Horn. Unless clean tech follows well-established rules of innovation and commercialization, the industry’s promise to provide sustainable sources of energy will fail.